TATA Health International Holdings Limited (01255) reported that as of 28 February 2026, the authorized share capital remained at 500.00 million ordinary shares with a par value of HKD 0.01 per share, translating to a total authorized share capital of HKD 5.00 million. The number of issued shares stood at 242.85 million, with no treasury shares reported.

The update confirmed that the public float requirement has been maintained for the period under review, with no adjustments to the share structure during the month. The company did not disclose any additional changes or arrangements in relation to issued shares, securities, or convertible instruments for the stated period.